Alyeska Investment Group
PLXP

Alyeska Investment Group’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Alyeska Investment Group’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2,813
Closed -$252K – 472
2015
Q4 		$252K Sell
2,813
-10,947
-80% -$1.05M ﹤0.01% 363
2015
Q3 		$1.54M Sell
13,760
-2,490
-15% -$287K 0.02% 353
2015
Q2 		$1.65M Buy
+16,250
New +$1.68M 0.02% 364

Other funds holding PLXP

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
LSVM
Lone Star Value Management Old Greenwich, Connecticut $52.7M AUM 30.18% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
TCM
Timpani Capital Management Milwaukee, Wisconsin $209M AUM 62.15% 1-Year Est. Return

Alyeska Investment Group's PLXP Position: Q1 2016 in Review

Alyeska Investment Group sold out of PLx Pharma Inc. Common Stock (PLXP) in Q1 2016, closing a stake of 2,813 shares — an estimated $252K sold.

Alyeska Investment Group first reported a position in PLXP in Q2 2015 and held it in 3 quarters. The position peaked at $1.65M in Q2 2015. 33 funds tracked by Wall St. Rank hold PLXP as of Q1 2016.

  • Alyeska Investment Group reported no remaining PLx Pharma Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • Alyeska Investment Group sold 2,813 PLx Pharma Inc. Common Stock shares in Q1 2016, an estimated $252K.
  • Alyeska Investment Group first reported a position in PLx Pharma Inc. Common Stock in Q2 2015 and held it in 3 quarters.
  • Alyeska Investment Group's PLx Pharma Inc. Common Stock position peaked at $1.65M in Q2 2015.
  • 33 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q1 2016.

Based on Alyeska Investment Group's 13F filing for Q1 2016, filed 16 May 2016.